Skip to main content

View full-text article in PMC

. 2014 Feb 25;2014:613157. doi: 10.1155/2014/613157

Table 3.

Autoantibodies in the study participants.

Autoantibodies	Group	Mean	S.d.	95% CI		Minimum	Maximum	P
Autoantibodies	Group	Mean	S.d.	Lower bound	Upper bound	Minimum	Maximum	P
Antiendothelial cells (OD)	Patients	0.684	0.211	0.509	0.579	0.229	0.955	0.004
Antiendothelial cells (OD)	Controls	0.598	0.193	0.444	0.494	0.215	0.775	0.004

Beta 2- glycoprotein I (OD)	Patients	0.665	0.344	0.595	0.1735	0.242	2.266	0.003
Beta 2- glycoprotein I (OD)	Controls	0.540	0.205	0.499	0.582	0.280	1.437	0.003

Platelet glycoprotein IIb/IIIa (OD)	Patients	0.351	0.100	0.331	0.372	0.225	0.718	0.001
Platelet glycoprotein IIb/IIIa (OD)	Controls	0.306	0.074	0.290	0.321	0.176	0.499	0.001

Anticardiolipin (OD)	Patients	0.552	0.180	0.515	0.589	0.228	1.161	0.001
Anticardiolipin (OD)	Controls	0.415	0.097	0.396	0.435	0.237	0.704	0.001